| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 171,0 M € | +8.1% | 158,2 M € | -0.8% | 159,4 M € | -19.6% | 198,2 M € | +62.2% | 122,2 M € | +19.0% | 102,7 M € | +22.0% | 84,2 M € | +20.7% | 69,7 M € | +101.0% | 34,7 M € | -5.1% | 36,6 M € | +29.0% | 28,3 M € | +6.5% | 26,6 M € | -26.1% | 36,0 M € | +112.4% | 17,0 M € | +17.1% | 14,5 M € | +45.6% | 9,9 M € | +1.3% | 9,8 M € | +25.9% | 7,8 M € | +64.7% | 4,7 M € | -18.8% | 5,8 M € | |
| EBITDA | 10,8 M € | -25.1% | 14,4 M € | +33.0% | 10,9 M € | -32.8% | 16,2 M € | +133.8% | 6,9 M € | +27.6% | 5,4 M € | +9.8% | 4,9 M € | +39.9% | 3,5 M € | +30.8% | 2,7 M € | -28.7% | 3,8 M € | +325.1% | 889,2 k € | -56.8% | 2,1 M € | +5.2% | 2,0 M € | +127.6% | 860,6 k € | -2.3% | 880,9 k € | +571.4% | 131,2 k € | -77.1% | 573,7 k € | +173.9% | 209,5 k € | -5.5% | 221,8 k € | -47.6% | 423,1 k € | |
| Operating profit | 9,9 M € | -24.2% | 13,1 M € | +18.9% | 11,0 M € | -24.9% | 14,6 M € | +209.3% | 4,7 M € | -18.6% | 5,8 M € | +28.8% | 4,5 M € | +35.1% | 3,3 M € | +59.9% | 2,1 M € | -43.1% | 3,7 M € | +325.7% | 861,9 k € | -58.1% | 2,1 M € | +9.3% | 1,9 M € | +70.7% | 1,1 M € | +156.5% | 429,5 k € | +76.7% | 243,1 k € | -68.9% | 781,1 k € | +296.4% | 197,0 k € | -16.9% | 237,0 k € | +76.6% | 134,2 k € | |
| Profit/loss | 6,6 M € | -30.3% | 9,5 M € | +42.4% | 6,7 M € | -32.9% | 9,9 M € | +250.4% | 2,8 M € | -21.3% | 3,6 M € | +9.6% | 3,3 M € | +9.4% | 3,0 M € | +159.9% | 1,2 M € | -61.5% | 3,0 M € | +166.8% | 1,1 M € | -18.1% | 1,4 M € | -33.0% | 2,1 M € | +77.5% | 1,2 M € | +370.9% | 245,3 k € | +167.1% | 91,8 k € | -81.6% | 498,8 k € | +257.8% | 139,4 k € | +25.7% | 110,9 k € | +85.7% | 59,7 k € | |
| Equity | 31,4 M € | +26.6% | 24,8 M € | +25.1% | 19,8 M € | +20.7% | 16,4 M € | +73.0% | 9,5 M € | +24.4% | 7,6 M € | +15.1% | 6,6 M € | +11.5% | 5,9 M € | +41.7% | 4,2 M € | +3.8% | 4,0 M € | +32.9% | 3,0 M € | +4.3% | 2,9 M € | +14.7% | 2,5 M € | +97.0% | 1,3 M € | -3.4% | 1,3 M € | +22.5% | 1,1 M € | +9.2% | 997,5 k € | +11.0% | 898,7 k € | +18.4% | 759,2 k € | +17.1% | 648,3 k € | |
| Total assets | 75,9 M € | +10.9% | 68,4 M € | +16.9% | 58,5 M € | -22.3% | 75,3 M € | +33.0% | 56,6 M € | +60.7% | 35,2 M € | +2.4% | 34,4 M € | -7.5% | 37,2 M € | +140.7% | 15,5 M € | -14.5% | 18,1 M € | +47.7% | 12,2 M € | +36.6% | 9,0 M € | -24.5% | 11,9 M € | +161.1% | 4,5 M € | -1.4% | 4,6 M € | +99.6% | 2,3 M € | -13.7% | 2,7 M € | -9.3% | 2,9 M € | +31.5% | 2,2 M € | -28.7% | 3,1 M € | |
| Cash | 343,6 k € | -86.0% | 2,4 M € | +44.1% | 1,7 M € | +45.3% | 1,2 M € | -0.4% | 1,2 M € | -19.0% | 1,4 M € | +14.3% | 1,3 M € | +40.0% | 905,9 k € | +334.1% | 208,7 k € | -91.0% | 2,3 M € | +1211.4% | 176,9 k € | -2.5% | 181,5 k € | -85.9% | 1,3 M € | +2841.0% | 43,7 k € | -69.8% | 144,8 k € | +86.4% | 77,7 k € | +366.7% | 16,6 k € | -61.4% | 43,1 k € | -67.6% | 132,9 k € | +134.7% | 56,6 k € | |
| Debts | 41,6 M € | +0.7% | 41,3 M € | +9.3% | 37,8 M € | -33.5% | 56,8 M € | +28.5% | 44,2 M € | +69.8% | 26,0 M € | -2.4% | 26,7 M € | -10.7% | 29,9 M € | +207.0% | 9,7 M € | -22.1% | 12,5 M € | +68.4% | 7,4 M € | +48.2% | 5,0 M € | -36.0% | 7,8 M € | +152.3% | 3,1 M € | -1.5% | 3,1 M € | +229.0% | 956,4 k € | -39.9% | 1,6 M € | -19.6% | 2,0 M € | +34.2% | 1,5 M € | -39.5% | 2,4 M € | |
| Staff | 48,8 | 42,7 | 39,1 | 34,5 | 33,3 | 31,9 | 29,6 | 23,6 | 0,8 | 0,8 | 0,9 | 0,9 | 0,9 | 0,9 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||||||||||||||||
Public limited company · Antwerpen · incorporated on 06/12/1988 · 48,8 ETP
Public limited company profitable and well capitalised. Cash position declining (-86.0%).
Solid counterparty for a standard engagement.
TRANSMARE CHEMIE is a Public limited company incorporated in 1988. Its main activity is: Wholesale of chemical products. Its registered office is in Antwerpen. It employs on average 48,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette